XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation
6 Months Ended
Aug. 29, 2020
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
 
The Company measures all stock-based compensation awards for employees and non-employee directors using a fair value method and records such expense, net of estimated forfeitures, in its consolidated financial statements. Currently, the Company’s stock-based compensation relates to restricted stock awards, stock options, restricted stock units and performance stock units. The Company’s restricted stock awards are considered nonvested share awards.
 
Stock-based compensation expense for the three and six months ended August 29, 2020 was approximately $8.2 million ($5.5 million after tax or $0.04 per diluted share) and approximately $15.9 million ($8.7 million after tax or $0.07 per diluted share), respectively. Stock-based compensation expense for the three and six months ended August 31, 2019 was approximately $12.1 million ($8.4 million after tax or $0.07 per diluted share) and approximately $31.4 million ($25.8 million after tax or $0.20 per diluted share), respectively. In addition, the amount of stock-based compensation cost capitalized for the six months ended August 29, 2020 and August 31, 2019 was approximately $0.3 million and $0.5 million, respectively.
 
Incentive Compensation Plans
 
The Company may grant awards under the Bed Bath & Beyond 2018 Incentive Compensation Plan (the “2018 Plan”) and the Bed Bath & Beyond 2012 Incentive Compensation Plan (the "2012 Plan"), although plan-based grants to date have been made solely under the 2012 Plan. The 2018 Plan includes an aggregate of 4.6 million shares of common stock authorized for issuance of awards permitted under the 2018 Plan, including stock options, stock appreciation rights, restricted stock awards, performance awards and other stock based awards. The 2018 Plan supplements the 2012 Plan, which amended and restated the Bed Bath & Beyond 2004 Incentive Compensation Plan (the “2004 Plan”). The 2012 Plan includes an aggregate of 43.2 million common shares authorized for issuance of awards permitted under the 2012 Plan (similar to the 2018 Plan). Outstanding awards that were covered by the 2004 Plan continue to be in effect under the 2012 Plan.
 
The terms of the 2012 Plan and the 2018 Plan are substantially similar and enable the Company to offer incentive compensation through stock options (whether nonqualified stock options or incentive stock options), restricted stock awards, stock appreciation rights, performance awards and other stock based awards, and cash-based awards. Grants are determined by the Compensation Committee of the Board of Directors of the Company for those awards granted to executive officers, and by the Board of Directors of the Company for awards granted to non-employee directors. Stock option grants generally become exercisable in either three or five equal annual installments beginning one year from the date of grant, subject, in general, to the recipient remaining in the Company’s service on specified vesting dates. Restricted stock awards generally become vested in five to seven equal annual installments beginning one to three years from the date of grant, subject, in general, to the recipient remaining in the Company’s service on specified vesting dates. Performance stock units generally vest over a period of three to four years from the date of grant dependent on the Company’s achievement of performance-based tests and subject, in general, to the executive remaining in the Company’s service on specified vesting dates.

The Company generally issues new shares for stock option exercises, restricted stock awards and vesting of restricted stock units and performance stock units. No grants have been made to date under the 2018 Plan, which expires in May 2028. The 2012 Plan expires in May 2022.

As described in further detail below, in fiscal 2020 and 2019, the Company granted stock-based awards to certain of the Company’s new executive officers as inducements material to their commencement of employment and entry into an employment agreement with the Company. The inducement awards were made in accordance with Nasdaq Listing Rule 5635(c)(4) and were not made under the 2012 Plan or the 2018 Plan.

Stock Options
 
Stock option grants were issued at fair market value on the date of grant and generally became exercisable in either three or five equal annual installments beginning one year from the date of grant, subject, in general, to the recipient remaining in the Company’s service on specified vesting dates. Option grants expired eight years after the date of grant. All option grants are nonqualified. During the six months ended August 29, 2020, the remaining 822,633 options outstanding were forfeited and there were no options outstanding as of August 29, 2020.

Restricted Stock
 
Restricted stock awards are issued and measured at fair market value on the date of grant and generally become vested in five to seven equal annual installments beginning one to three years from the date of grant, subject, in general, to the recipient remaining in the Company’s service on specified vesting dates. Vesting of restricted stock is based solely on time vesting. As of August 29, 2020, unrecognized compensation expense related to the unvested portion of the Company’s restricted stock awards was $37.1 million, which is expected to be recognized over a weighted average period of 3.2 years.
 
Changes in the Company’s restricted stock for the six months ended August 29, 2020 were as follows:
(Shares in thousands)
Number of Restricted
Shares
 
Weighted Average
Grant-Date Fair
Value
Unvested restricted stock, beginning of period
2,445

 
$
35.50

Granted
95

 
8.09

Vested
(557
)
 
43.25

Forfeited
(446
)
 
33.40

Unvested restricted stock, end of period
1,537

 
$
31.61


 
Restricted Stock Units ("RSUs")

RSUs are issued and measured at fair market value on the date of grant and generally become vested in one to three equal annual installments beginning one year from the date of grant, subject, in general, to the recipient remaining in the Company’s service on specified vesting dates. RSUs are converted into shares of common stock upon vesting. During the six months ended August 29, 2020, the Company granted 1,497,916 of RSUs with a weighted average grant-date fair value of $9.63. As of August 29, 2020, unrecognized compensation expense related to the unvested portion of the Company’s RSUs was $13.1 million, which is expected to be recognized over a weighted average period of 2.7 years.

Performance Stock Units ("PSUs")
 
PSUs are issued and measured at fair market value on the date of grant. Vesting of PSUs awarded to certain of the Company’s executives is dependent on the Company’s achievement of a performance-based test during a one-year period from the date of grant and during a three-year period from the date of grant and, assuming achievement of the performance-based test, time vesting over periods of up to four years, subject, in general, to the executive remaining in the Company’s service on specified vesting dates. For PSUs granted in fiscal 2019, performance during the one-year period is based on Earnings Before Interest and Taxes ("EBIT") relative to a target amount and performance during the three-year period is based on a combination of total shareholder return relative to a peer group of the Company and cumulative EBIT relative to a target amount. The achievement of PSU awards ranges from a floor of zero to a cap of 150% of target achievement. For awards granted in fiscal 2018 and prior, performance during the three-year period were based on Return on Invested Capital ("ROIC") or a combination of EBIT margin and ROIC relative to a peer group. PSUs are converted into shares of common stock upon payment following vesting. Upon grant of the PSUs, the Company recognizes compensation expense related to these awards based on the Company’s estimate of the percentage of the award that will be achieved. The Company evaluates the estimate on these awards on a quarterly basis and adjusts compensation expense related to these awards, as appropriate. As of August 29, 2020, there was $5.0 million of unrecognized compensation expense associated with these awards, which is expected to be recognized over a weighted average period of 2.8 years.

The fair value of the PSUs granted in fiscal 2020 for which performance during the three-year period will be based on a relative three-year Total Shareholder Return ("TSR") goal relative to a peer group was estimated on the date of the grant using a Monte Carlo simulation that uses the assumptions noted in the following table.
 
 
Six Months Ended
Monte Carlo Simulation Assumptions
 
August 29, 2020
Risk Free Interest Rate
 
0.27
%
Expected Dividend Yield
 
%
Expected Volatility
 
51.30
%
Expected Term
 
3 years



Changes in the Company’s PSUs for the six months ended August 29, 2020 were as follows:
(Shares in thousands)
Number of Performance
Stock Units
 
Weighted Average
Grant-Date Fair
Value
Unvested performance stock units, beginning of period
1,414

 
$
21.57

Granted
558

 
9.60

Vested
(343
)
 
37.50

Forfeited or performance condition adjustments
(249
)
 
17.96

Unvested performance stock units, end of period
1,380

 
$
13.40



Inducement Awards

In fiscal 2020 and 2019, the Company granted stock-based awards to certain of the Company’s new executive officers as inducements material to their commencement of employment and entry into an employment agreement with the Company. These inducement awards were approved by the Compensation Committee of the Board of Directors of the Company and did not require shareholder approval in accordance with Nasdaq Listing Rule 5635(c)(4).

RSUs granted as inducement awards are issued and measured at fair market value on the date of grant and generally become vested in one to three equal annual installments beginning one year from the date of grant, subject, in general, to the recipient remaining in the Company’s service on specified vesting dates. Changes in the RSUs granted as inducement awards for the six months ended August 29, 2020 were as follows:
(Shares in thousands)
 
Number of Restricted
Stock Units
 
Weighted Average
Grant-Date Fair
Value
Unvested restricted stock units, beginning of period
 
579

 
$
13.65

Granted
 
816

 
6.33

Vested
 
(274
)
 
13.65

Forfeited
 

 

Unvested restricted stock units, end of period
 
1,121

 
$
8.32



On November 4, 2019, in connection with the appointment of the Company’s new President and Chief Executive Officer, the Company granted inducement awards consisting of 578,753 RSUs, which are included in the table above, and 273,735 PSU awards. The PSUs will vest, if at all, on November 4, 2021, based on performance goals requiring the President and CEO to prepare and deliver to the Board of Directors key objectives and goals for the Company and the strategies and initiatives for the achievement of such objectives and goals, and the President and CEO's provision of updates to the Board of Directors regarding achievement of such goals and objectives, and subject, in general, to the new President and CEO remaining in the Company’s service through the vesting date.

Other than with respect to the vesting schedule described above, these inducement awards are generally subject to substantially the same terms and conditions as awards that are made under the 2018 Plan. As of August 29, 2020, unrecognized compensation expense related to the unvested portion of the RSU and PSU inducement awards was $6.9 million and $2.2 million, respectively, which is expected to be recognized over a weighted average period of 2.0 years and 1.2 years, respectively. Each inducement award recipient must hold at least fifty percent (50%) of the after-tax shares of common stock received pursuant to the inducement awards until they have satisfied the terms of the Company’s stock ownership guidelines.